These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 21817854)
81. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. Babiuk S; Baca-Estrada M; Babiuk LA; Ewen C; Foldvari M J Control Release; 2000 May; 66(2-3):199-214. PubMed ID: 10742580 [TBL] [Abstract][Full Text] [Related]
83. High frequency ultrasound to assess skin thickness in healthy adults. Van Mulder TJ; de Koeijer M; Theeten H; Willems D; Van Damme P; Demolder M; De Meyer G; Beyers KC; Vankerckhoven V Vaccine; 2017 Mar; 35(14):1810-1815. PubMed ID: 27496276 [TBL] [Abstract][Full Text] [Related]
84. [Transcutaneous applications for vaccination and immunotherapy]. Krämer I; Zabel F; Kündig TM; Johansen P Praxis (Bern 1994); 2014 Oct; 103(21):1247-55. PubMed ID: 25305116 [TBL] [Abstract][Full Text] [Related]
85. A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection. Ishii Y; Nakae T; Sakamoto F; Matsuo K; Matsuo K; Quan YS; Kamiyama F; Fujita T; Yamamoto A; Nakagawa S; Okada N J Control Release; 2008 Oct; 131(2):113-20. PubMed ID: 18700159 [TBL] [Abstract][Full Text] [Related]
86. Analysis of immune response induction mechanisms implicating the dose-sparing effect of transcutaneous immunization using a self-dissolving microneedle patch. Ito S; Hirobe S; Yamashita R; Sugiyama A; Takeuchi H; Eguchi R; Yoshida J; Oyamada T; Tachibana M; Okada N Vaccine; 2022 Feb; 40(6):862-872. PubMed ID: 34998604 [TBL] [Abstract][Full Text] [Related]
87. Skin thickness in young infants and adolescents: Applications for intradermal vaccination. Saitoh A; Aizawa Y; Sato I; Hirano H; Sakai T; Mori M Vaccine; 2015 Jun; 33(29):3384-91. PubMed ID: 25944297 [TBL] [Abstract][Full Text] [Related]
88. Development of the prenatal cutaneous antigen-presenting cell network. Elbe-Bürger A; Schuster C Immunol Cell Biol; 2010; 88(4):393-9. PubMed ID: 20212508 [TBL] [Abstract][Full Text] [Related]
90. Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour. Ng KW; Pearton M; Coulman S; Anstey A; Gateley C; Morrissey A; Allender C; Birchall J Vaccine; 2009 Oct; 27(43):5948-55. PubMed ID: 19679220 [TBL] [Abstract][Full Text] [Related]
91. Epidermal micro-perforation potentiates the efficacy of epicutaneous vaccination. Hervé PL; Dhelft V; Plaquet C; Rousseaux A; Bouzereau A; Gaulme L; Tilleul S; Ligouis M; Donne N; Lambert PH; Hong-Thai P; Wijagkanalan W; Sampson HA; Mondoulet L J Control Release; 2019 Mar; 298():12-26. PubMed ID: 30738084 [TBL] [Abstract][Full Text] [Related]
92. Characteristics of immune induction by transcutaneous vaccination using dissolving microneedle patches in mice. Hirobe S; Susai R; Takeuchi H; Eguchi R; Ito S; Quan YS; Kamiyama F; Okada N Int J Pharm; 2021 May; 601():120563. PubMed ID: 33811967 [TBL] [Abstract][Full Text] [Related]
93. Transcutaneous immunization and immunostimulant strategies. Glenn GM; Kenney RT; Hammond SA; Ellingsworth LR Immunol Allergy Clin North Am; 2003 Nov; 23(4):787-813. PubMed ID: 14753392 [TBL] [Abstract][Full Text] [Related]
94. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Laurent A; Mistretta F; Bottigioli D; Dahel K; Goujon C; Nicolas JF; Hennino A; Laurent PE Vaccine; 2007 Aug; 25(34):6423-30. PubMed ID: 17640778 [TBL] [Abstract][Full Text] [Related]
95. Current opportunities and challenges in intradermal vaccination. Chen D; Bowersock T; Weeratna R; Yeoh T Ther Deliv; 2015; 6(9):1101-8. PubMed ID: 26458019 [TBL] [Abstract][Full Text] [Related]
96. Mechanisms of innate events during skin reaction following intradermal injection of seasonal influenza vaccine. Gonnet J; Poncelet L; Meriaux C; Gonçalves E; Weiss L; Tchitchek N; Pedruzzi E; Soria A; Boccara D; Vogt A; Bonduelle O; Hamm G; Ait-Belkacem R; Stauber J; Fournier I; Wisztorski M; Combadiere B J Proteomics; 2020 Mar; 216():103670. PubMed ID: 31991189 [TBL] [Abstract][Full Text] [Related]
98. Intradermal delivery of vaccines: potential benefits and current challenges. Hickling JK; Jones KR; Friede M; Zehrung D; Chen D; Kristensen D Bull World Health Organ; 2011 Mar; 89(3):221-6. PubMed ID: 21379418 [TBL] [Abstract][Full Text] [Related]
99. Understanding the basis of transcutaneous vaccine delivery. Gamazo C; Pastor Y; Larrañeta E; Berzosa M; Irache JM; Donnelly RF Ther Deliv; 2019 Jan; 10(1):63-80. PubMed ID: 30730825 [TBL] [Abstract][Full Text] [Related]
100. An update on the use of laser technology in skin vaccination. Chen X; Wang J; Shah D; Wu MX Expert Rev Vaccines; 2013 Nov; 12(11):1313-23. PubMed ID: 24127871 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]